Magri argues that managed care organizations are having trouble treating their diabetic patients and will welcome a new option.

FORBES: Merck Starts Diabetes Race

Readying Merck's big drug launch, Magri emphasizes that the diabetes market is one that will develop over years, not months.

FORBES: Magazine Article

"I know our customers are going to embrace Januvia from the moment we put it on the marketplace, " says Patrick Magri , the Merck vice president who will lead the marketing effort for the drug.

FORBES: Magazine Article